Organization · Venture Capital
NSG Ventures
NSG Ventures is a Singapore-based global venture capital firm focused on early-stage biotechnology companies, particularly those developing transformative solutions for health challenges. The firm combines capital investment with scientific expertise and infrastructure support.
Overview
What NSG Ventures does
What NSG Ventures is
NSG Ventures is a Singapore-based global venture capital firm focused on early-stage biotechnology companies, particularly those developing transformative solutions for health challenges. The firm combines capital investment with scientific expertise and infrastructure support.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find NSG Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
NSG Ventures as a funder
Investment thesis
NSG Ventures backs and builds early-stage transformative drug discovery companies globally, focusing on scientific breakthroughs to tackle diseases.
Focus narrative
NSG Ventures invests in the biotechnology sector, targeting transformative companies that are developing solutions for medical breakthroughs. The firm emphasizes partnerships with exceptional teams to push scientific boundaries and advance healthcare, particularly in drug discovery and life sciences.
Value beyond capital
NSG Ventures adds value to its portfolio companies by providing access to a robust lab infrastructure through NSG Bio, along with scientific expertise and a supportive biotech community. The firm emphasizes long-term partnerships and company-building resources to help founders navigate the complexities of the biotech landscape.
Focus and fit
- Stages
- Seed · Series A · Growth Equity · Pre-IPO
- Regions
- Global · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
Notable portfolio companies include: Lunit: A medical AI provider focused on healthcare solutions, involved in cancer diagnostics. Medra: Specializes in AI-driven medical technologies, developing a Physical AI Scientist platform for drug discovery. Open Protein: Engaged in protein engineering and biotechnology, developing AI-accelerated protein design tools. Biotix: Focused on biotechnological innovations, creating sustainable microbiome-derived ingredients for skin health.
Common questions
What to know about NSG Ventures
Upseed classifies NSG Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.